BioStock publishes rights issue article about Prolight Diagnostics

On December 7, BioStock pulished rights issue article about Prolight Diagnostics in Swedish, among other, it is stated that both the Board and Prolight group management are participating in the rights issue. Read the article: "Emission ska ta Prolight Diagnostics patientnära analys till marknaden", https://prolightdx.com/en/mediaeng/articles/.

For further information, please contact:
Prolight Diagnostics AB (publ)
E-mail: info@prolightdx.com
Telephone: +46 73 582 39 87
Website: www.prolightdx.com/en/

About Us
Prolight Diagnostics AB develops innovative Point-of-Care (POC) systems. These are small, portable instruments and disposable cartridges for performing in-vitro diagnostic (IVD) tests from a drop of blood.
We want to offer the foremost POC systems on the market for quick, reliable diagnosis of acute events. Our launch product will be for the measurement of troponin, to aid in the rule-in and rule-out of myocardial infarction.
 
The company’s share is traded on the NGM Nordic SME marketplace, under the ticker PRLD.

Attachments
BioStock publishes rights issue article about Prolight Diagnostics

BioStock publishes rights issue article about Prolight Diagnostics
Back

Subscribe